Involvement of ATP-sensitive K+ channels in the peripheral antinociceptive effect induced by the α2-adrenoceptor agonist xylazine

Journal of Pharmacological Sciences

Volumn 111, Issue 4, 2009, Pages 323-327

  Romero, Thiago Roberto Lima ^a   Duarte, Igor Dimitri Gama ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Peripheral antinociception; Xylazine

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DEQUALINIUM; GLIBENCLAMIDE; PAXILLINE; POTASSIUM CHANNEL; PROSTAGLANDIN E2; TETRYLAMMONIUM; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CALCIUM CONDUCTANCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ELECTRIC POTENTIAL; HYPERALGESIA; MALE; MUSCLE RELAXATION; NONHUMAN; RAT;

EID: 74849136148     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09103FP     Document Type: Article

References (34)

1. Thornbury KD, Ward SM, Dalziel HH, Carl A, Westfall DP, Sanders KM. Nitric oxide and nitrosocysteine mimic non-adrenergic, noncholinergic hyperpolarization in canine proximal colon. Am J Physiol. 1991;261:G553-G557.
2. + channels in cultured vascular smooth muscle cells. Circ Res. 1994;74:471-476.
3. + channels. J Physiol. 1995;486:47-58.
4. 2+-activated K channels. Am J Physiol. 1997;273:H76-84.
5. Rudy B. Diversity and ubiquity of K channels. Neuroscience. 1988;25:729-749.
6. Ocaña M, Cendán CM, Cobos EJ, Entrena JM, Baeyens JM. Potassium channels and pain: present realities and future opportunities. Eur J Pharmacol. 2004;500:203-219.
7. + channels. Br J Pharmacol. 2000;129:110-114.
8. + channels in the peripheral antinociceptive effect induced by dipyrone. Eur J Pharmacol. 2002;444:47-52.
9. + channels activation. Life Sciences. 2004;74:2577-2591.
10. Kroneberg G, Oberdorf A, Hoffmeister F, Wirth W. [On the pharmacology of 2-(2,6-dimethylphenylamino)-4H-5,6-dihydro-1,3-thiazine (Bayer 1470), a substance inhibitory for adrenergic and cholinergic neurons]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967;256:257-280. (in German)
11. Hsu WS. Xylazine-induced depression and its antagonism by alpha adrenergic blocking agents. J Pharmacol Exp Ther. 1981;218:188-192.
12. Willian WMIII, John H, Roman ST, Richard BM. Fármacos usados na medicação pré-anestésica. [Drugs used in anesthesia.] In: Willian WM III. Manual de anestesia veterinária. [Handbook of veterinary anesthesia.] 3rd ed. Porto Alegre, RS, Brazil: Artmed; 2001. p. 31-44. (in Portuguese)
13. 2C-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine. Eur J Pharmacol. 2009;608:23-27.
14. 2-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat. Eur J Pharmacol. 2009;613:64-67.
15. + channels. Annu Rev Pharmacol Toxicol. 1993;33:597-637.
16. Cook NS, Quast U. Potassium channel pharmacology. In: Cook NS, editor. Potassium channels: structure, classification, function, and therapeutic potential. Chichester: Ellis Horwood; 1990. p. 181-225.
17. Dunn PM. Dequalinium, a selective blocker of the slow afterhyperpolarization in rat sympathetic neurons in culture. Eur J Pharmacol. 1994;252:189-194.
18. + channels in rat mesenteric arterial cells. Eur J Pharmacol. 1999;372:103-107.
19. Green AF, Young PA. A comparison of heat and pressure analgesiometric methods in rats. Br J Pharmacol Chemother. 1951;6:572-585.
20. Randall LO, Sellito JJ. A method for measurement of analgesic activity on inflamed tissues. Arch Int Pharmacodyn Ther. 1957;111:409-419.
21. + channels in rat dorsal root ganglion neurons. Eur J Anesthesiol. 2007;24:934-941.
22. 2-adrenocptor, GABA B and κ-opioid receptor agonists. Br J Pharmacol. 1993;110:1049-1054.
23. 2-adrenoceptors. Br J Phamarcol. 1999;126:1214-1220.
24. 2-Adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons. Pain. 1997;69:179-190.
25. Kawano T, Zoga V, McCallum JB, Wu HE, Gemes G, Liang MY, et al. ATP-Sensitive potassium currents in rat primary afferent neurons: Biophysical, pharmacological properties, and alterations by painful nerve injury. Neuroscience. 2009;162:431-443.
26. Babenko AP, Aguilar-Bryan L, Bryan J. A view of sur-KIR6.X, KATP channels. Annu Rev Physiol. 1998;60:667-687.
27. Duarte IDG, Ferreira SH. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur J Pharmacol. 1992;321:171-174.
28. Sánchez JA, Gonoi T, Inagaki N, Katada T, Seino S. Modulation of reconstituted ATP-sensitive K(+)-channels by GTP-binding proteins in a mammalian cell line. J Physiol. 1998;507:315-324.
29. Wada T, Otsu T, Hasegawa Y, Mizuchi A, Ono H. Characterization of alpha 1-adrenoceptor subtypes in rat spinal cord. Eur J Pharmacol. 1996;312:263-266.
30. Soares AC, Leite R, Tatsuo MA, Duarte ID. Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur J Pharmacol. 2000;400:67-71.
31. 2-induced hyperalgesic paw. Br J Pharmacol. 2001;134:127-131.
32. + channels, and sodium nitroprusside and dibutyryl-cGMP. Eur J Pharmacol. 2004;489:59-65.
33. + channels. Science. 1990;247:852-854.
34. + channels in the cardiovascular system. Am J Physiol. 1991;261:H1675-H1690.